Archival Version

Asthma is a chronic illness that affects more than 23 million adults in the United States. In addition to respiratory symptoms associated with the disease, individuals with asthma are also more likely to experience depression and anxiety. The BreathEasy team designed a mobile application built on the latest clinical guidelines for treatment and self-monitoring for patients with asthma. Patients with asthma used the application on smartphones to capture and report observations of daily living (ODLs) such as use of controller and rescue medications, asthma symptoms (including peak flow rates), depression and anxiety symptoms, encounters with asthma triggers, physical activity levels (including accelerometer based data), sleeping problems, and smoking. Clinicians used a web based dashboard with simple analysis and visualization tools that allowed them to quickly view the patients' data, evaluate their health statuses, and communicate changes in treatment or monitoring. This data collection contains the ODL data recorded by the patients.

哮喘是一种慢性疾病，在美国影响超过2300万成年人群体。除该疾病伴发的呼吸道症状外，哮喘患者还更易出现抑郁与焦虑情绪。BreathEasy团队开发了一款基于最新临床诊疗指南的移动应用程序，用于哮喘患者的治疗与自我监测。哮喘患者可通过智能手机使用该应用，记录并上报日常观察指标（Observations of Daily Living, ODLs），具体包括控制类药物与急救药物的使用情况、哮喘相关症状（含峰流速值）、抑郁与焦虑症状、哮喘诱因接触情况、身体活动水平（含基于加速度计的监测数据）、睡眠问题以及吸烟行为。临床医生可通过配备简易分析与可视化工具的网页端控制面板，快速查看患者数据、评估其健康状态，并沟通调整治疗或监测方案。本数据集收录了患者所记录的日常观察指标数据。